​​​​​

Photobiomodulation Equipment and Training - THOR Photomedicine

Select Region

Information contained on this page may not be appropriate for your region, please select your region from below. To navigate back to this region selector, please click "Region" in the footer.
Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

What is Photobiomodulation (PBM Therapy)?

Photobiomodulation (PBM Therapy) previously known as Low Level Laser Therapy (LLLT) is the application of red and near infra-red light over injuries or lesions to improve wound and soft tissue healing, reduce inflammation and give relief for both acute and chronic pain. First developed in 1967, it is now commonly referred to as PBM.

Photobiomodulation is used to: increase the speed, quality and tensile strength of tissue repair; resolve inflammation and relieve pain (analgesia).

The red and near infrared light (600nm-1000nm) commonly used in PBM can be produced by laser or high intensity LEDs. The intensity of PBM lasers and LED's is not high like a surgical laser. There is no heating effect.

The effects of PBM are photochemical (like photosynthesis in plants). When the correct intensity and treatment times are used, red and near infrared light reduces oxidative stress and increases ATP. This improves cell metabolism and reduce inflammation. These effects can be enhanced with pulses however when analgesia is required there is a second mechanism which works best when a strong continuous beam is applied.

PBM devices are typically delivering 10mW - 500mW (0.01 -> 0.01 Watts). The power density typically ranges from 0.005W/Cm² -> 5 W/Cm².

PBM is popularly used for soft tissue injuries, joint conditions, neuropathic pain, non-healing leg and pressure ulcers.

NEWS The Lancet publishes landmark review of PBM for neck pain read more and listen to interview here

Introduction to PBM Video

Introduction to PBM and dose response by Prof. Michael Hamblin, Wellman Centre for Photomedicine, Harvard Medical School
Source: International Dose Response Society


Download 'PBM dose review (PDF)' This paper from Harvard Medical School reviews the PBM mechanisms and the biphasic dose response. It summarises the molecular and cellular mechanisms of PBM, gives a scientific explanation for the biphasic dose response (why a low dose has a stimulatory effect and why a high dose inhibits). Low power densities tend to get better healing and anti-inflammatory effects where higher power densities are more likely to inhibit (which may be useful if you just want an analgesic effect). I have to disclose an interest in this paper because I am a co-author. James Carroll CEO THOR Photomedicine.

How PBM works


Product information and purchase enquiry

Sorry for the long form.

We are a global company and our computer needs to know who to direct your enquiry to.

* Mandatory field - this automatically directs your enquiry to the correct department

[top]



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates

​​​​​